Talk:Granulocyte colony-stimulating factor

From Wikipedia, the free encyclopedia

Molecular and Cellular Biology WikiProject This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The current monthly improvement drive is Signal transduction.
Start This article has been rated as Start-Class on the assessment scale.
Mid This article is on a subject of Mid-importance within molecular and cellular biology.

Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need.

A complete merger would seem to taint the information with a commercial bias. Filgrastim is a product that a profit-motivated company is attempting to sell, whereas G-CSF is a chemical produced within the body. Filgrastim should, however, be mentioned under a subheading of the general G-CSF article, with the subheading title "Therapeutic Applications" or some equivalent.



I don't think that the article G-CSF should be merged with filgrastim. In fact, structural description and mechanism of action of (naturally occuring) cytokines should be separated from (genetically engeneered) cytokines produced by drug companies, in order to avoid bias. Same for eg GM-CSF and sagramostim.